Shares of Oxford Nanopore Technologies plc (LON:ONT – Get Free Report) have been given a consensus rating of “Moderate Buy” by the six analysts that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is GBX 198.60.
Several brokerages have commented on ONT. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a GBX 195 target price on shares of Oxford Nanopore Technologies in a report on Thursday, August 20th. Berenberg Bank reduced their target price on shares of Oxford Nanopore Technologies from GBX 220 to GBX 200 and set a “buy” rating for the company in a report on Wednesday, August 19th. Peel Hunt restated a “hold” rating and issued a GBX 153 price target on shares of Oxford Nanopore Technologies in a research note on Monday, July 13th. Royal Bank Of Canada reaffirmed an “outperform” rating and set a GBX 225 price objective on shares of Oxford Nanopore Technologies in a research report on Tuesday, May 26th. Finally, Citigroup cut Oxford Nanopore Technologies to a “buy” rating in a research report on Monday, July 20th.
View Our Latest Research Report on ONT
Oxford Nanopore Technologies Stock Performance
Oxford Nanopore Technologies (LON:ONT – Get Free Report) last posted its quarterly earnings data on Wednesday, August 19th. The company reported GBX (4.90) EPS for the quarter. Oxford Nanopore Technologies had a negative return on equity of 35.45% and a negative net margin of 54.66%.
Oxford Nanopore Technologies Company Profile
Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.
Featured Stories
- Five stocks we like better than Oxford Nanopore Technologies
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Receive News & Ratings for Oxford Nanopore Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Nanopore Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
